The largest database of trusted experimental protocols

Biocoll solution

Manufactured by Harvard Bioscience
Sourced in Germany

Biocoll solution is a laboratory reagent used for the separation and isolation of cells and cellular components. It is a density gradient medium that allows for the separation of different cell types based on their density. The core function of Biocoll solution is to facilitate the isolation and purification of specific cell populations from complex biological samples.

Automatically generated - may contain errors

6 protocols using biocoll solution

1

Extraction of PBMCs from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 8

Human whole blood from healthy donors (in house) and whole blood from cynomolgus monkey (retrieved from LPT Laboratory of Pharmacology and Toxicology, Hamburg, Germany) was collected in Li-Heparin containing S-Monovette® (scientific laboratory instruments, apparatus and equipment for clinical use) containers (Sarstedt). Blood was transferred to 50 ml conical tubes and mixed with an equal volume of PBS containing 2% fetal bovine serum (Sigma, #F7524) and 2 mM EDTA. Diluted blood was transferred to SepMate® (cell separation equipment)-50 tubes (StemCell Technologies® (cell separation equipment), #86450) containing 15 ml Biocoll solution (Biochrom, #L6115) and centrifuged for 10 min at 1200×g. Supernatant was transferred into a 50 ml conical tube, diluted to 45 ml with PBS and centrifuged for 8 min at 300×g. Supernatant was discarded, cell pellet resuspended in 1 ml PBS and cells counted using a Neubauer chamber.

+ Open protocol
+ Expand
2

Isolation of Human Monocytes from PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral Blood Mononuclear Cells (PBMC) were purified from whole blood by density gradient centrifugation using the Biocoll Solution (Cat No. 6715, Biochrom, Berlin, Germany) according to the manufacturer´s instructions. Monocytes were isolated from PBMCs by positive selection with magnetic beads using the EasySepTM Human CD14 Positive Selection Kit II (Cat No. 17858, Stemcell Technologies, Cologne, Germany) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
3

Longitudinal CLL Patient Blood Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was obtained from 71 patients with CLL from 2007 to 2019 after confirmed diagnosis. Median time between diagnosis and sample acquisition was 4 years (interquartile range 2–9 years). All experiments have been approved by the appropriate ethics committee (Ethics Committee of the University of Tübingen vote 13/2007 V) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all patients prior to initiation of experiments. Peripheral blood mononuclear cells (PBMC) were isolated using density gradient centrifugation using Biocoll Solution (Biochrom AG, Berlin, Germany) and thereafter stored in liquid nitrogen. Mean observational time for patients was 114 months (95% CI 96.8–132.6 months). Diagnosis was based on the iwCLL guideline [31 ]. Classification of CLL cases was performed according to the recent Rai and Binet classification systems [2 –5 (link)]. Cytogenetic analyses were performed with standardized methods at the medical care center (MVZ) Dortmund laboratory.
+ Open protocol
+ Expand
4

Isolation of Maternal Cells from Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Maternal blood samples were immediately transferred into nonphysiological conditions and left overnight before separation by density gradient centrifugation as previously described (Sitar et al. 2005). Briefly, maternal blood samples were mixed with an equal volume of 1× medium‐199 with Earle salts (Sigma‐Aldrich, St Louis, MO) and immediately, 15% of ACD‐A was added to blood samples. The osmolarity of these solutions was adjusted to 320 mOsm/L using NaCl (20 mEq/10 mL).
Diluted blood samples were overlaid onto a Biocoll solution (Biochrom AG, Berlin, Germany) having a density of 1.072 g/L into a cell separation device. Centrifugation was run for 20 min at 400 × g. Cells floating at the interface were retrieved out of the separation device previously described (Sitar et al. 2005). Slides for FISH investigation were obtained by cytocentrifugation. The procedure took about 2 h with a capacity of four samples per run.
+ Open protocol
+ Expand
5

Isolating PBMCs from Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood of healthy men and of patients with depression was collected via venipuncture, diluted with PBS, carefully loaded on Biocoll solution (BioChrom, L6113), and centrifuged at 800 g for 20 min (brakeless running down). PBMCs were enriched by selecting the interphase of the Biocoll gradient. PBMCs of the interphase were washed two times with ice-cold PBS. PBMCs were resuspended in RPMI and plated at 4×105 cells/cm2. After recovery for 6 h, cells were treated with 888 nM (120 ng/ml) AMI, 1,695 nM (500 ng/ml) fluoxetine (FLX), or 365 nM (120 ng/ml) PAR. Concentrations had been chosen to match therapeutic concentrations in the serum according to the consensus guidelines for therapeutic drug monitoring in psychiatry [49] .
+ Open protocol
+ Expand
6

Isolation of CD4+ T Cells from Peripheral Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was obtained from 3 healthy volunteers, two females and 1 male, aged between 25 and 42 years. Written informed consent was obtained from each participant and the protocol was supervised and approved by the Clinical Research Ethics Committee of the Alicante General Hospital (HGUA). Peripheral blood mononuclear cells (PBMCs) were isolated by gradient centrifugation using Biocoll solution (Biochrom, Berlin, Germany). CD4+ cells were then isolated from PBMCs by immunomagnetic selection using an EasySepTM Human CD4+ T cell isolation kit (StemCell Technologies, Vancouver, BC, Canada).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!